Neda Safarzadeh
Investor Relations Contact at ARCTURUS THERAPEUTICS HOLDINGS INC.
Profile
Neda Safarzadeh is currently the Head-Marketing, Investor & Public Relations at Arcturus Therapeutics Ltd.
since 2013 and the VP, Head-Marketing, Investor & Public Relations at Arcturus Therapeutics Holdings, Inc. since 2022.
Previously, she worked as the Head-Marketing, Public & Investor Relations at Marker Therapeutics, Inc. in 2022.
She also held a position in Investor Relations & Media Contact at Arcturus Therapeutics Holdings, Inc. Additionally, Ms. Safarzadeh completed her undergraduate degree at the University of California San Diego.
Neda Safarzadeh active positions
| Companies | Position | Start |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Investor Relations Contact | 2022-11-30 |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Investor Relations Contact | 2013-03-31 |
Former positions of Neda Safarzadeh
| Companies | Position | End |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Investor Relations Contact | 2022-11-30 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Investor Relations Contact | 2022-01-01 |
Training of Neda Safarzadeh
| University of California San Diego | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| MARKER THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Neda Safarzadeh
